Market-Moving News for July 8th
$CRKN
$GRFS
$SEDG
Industrial Machinery/Components
Technology
Biotechnology: Pharmaceutical Preparations
Health Care
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/20/2024 | Sell → Neutral | Guggenheim | ||
| 11/15/2024 | $23.00 → $9.00 | Equal-Weight → Underweight | Morgan Stanley | |
| 11/7/2024 | $35.00 → $11.00 | Outperform → Neutral | Mizuho | |
| 11/7/2024 | $16.00 → $11.00 | Hold | TD Cowen | |
| 11/7/2024 | $21.00 → $14.00 | Neutral → Underperform | BofA Securities | |
| 11/7/2024 | $17.00 → $9.00 | Neutral → Underweight | Piper Sandler | |
| 10/21/2024 | $35.00 → $16.00 | Buy → Hold | TD Cowen | |
| 10/17/2024 | $10.00 | Neutral → Sell | Guggenheim |
4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)
4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)
3 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)
6-K - Grifols SA (0001438569) (Filer)
6-K - Grifols SA (0001438569) (Filer)
10-Q - Crown Electrokinetics Corp. (0001761696) (Filer)
SC 13G/A - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Subject)
SC 13G/A - Grifols SA (0001438569) (Subject)
SC 13G - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Subject)
Guggenheim upgraded SolarEdge Technologies from Sell to Neutral
Morgan Stanley downgraded SolarEdge Technologies from Equal-Weight to Underweight and set a new price target of $9.00 from $23.00 previously
Mizuho downgraded SolarEdge Technologies from Outperform to Neutral and set a new price target of $11.00 from $35.00 previously
4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)
4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)
4 - SOLAREDGE TECHNOLOGIES, INC. (0001419612) (Issuer)
Sends Letter to Board Detailing Board's Conflicts of Interest and History of Poor Capital Allocation Expresses Urgent Need for Independent Directors and Proper Oversight to Unlock Value Believes Rumored Brookfield Transaction Substantially Undervalues Grifols Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. ("Grifols" or the "Company") (BME: GRF) (NASDAQ:GRFS) class A shares, today sent a letter to the Grifols Board of Directors (the "Board"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241107873955/en/Historical Forward EV/EBITDA Multip
Zvi Lando steps down as CEO, and Company initiates a search for new CEO Ronen Faier, previously Chief Financial Officer, appointed Interim CEO Ariel Porat, Senior VP Finance, appointed CFO as part of the Company's previously announced CFO Succession Plan SolarEdge Technologies, Inc. ("SolarEdge") (NASDAQ:SEDG), a global leader in smart energy technology, announced that Zvi Lando has stepped down as SolarEdge's Chief Executive Officer. The Company's Board of Directors has initiated a search for a new CEO with the support of a leading global executive search firm, and has appointed Ronen Faier, previously Chief Financial Officer, to serve as Interim Chief Executive Officer, effective to
SolarEdge Home Battery customers will be able to save by charging with low-cost, clean energy – fully automated by Kraken Octopus Energy customers in the UK and US first to benefit from lower energy bills SolarEdge systems around the world to expand Kraken's 'Virtual Power Plant' potential and turbocharge the smart grid Global clean tech leaders Kraken Technologies and SolarEdge Technologies, Inc. ("SolarEdge") (NASDAQ:SEDG) are today announcing a strategic partnership to unlock low-cost, green energy for SolarEdge Home Battery customers around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724918332/
Global clean tech leaders Kraken Technologies and SolarEdge Technologies, Inc. ("SolarEdge") (NASDAQ:SEDG) are today announcing a strategic partnership to unlock low-cost, green energy for SolarEdge Home Battery customers around the world. SolarEdge batteries will be integrated into Kraken – the world's fastest growing energy platform and the technology behind Octopus Energy. This will allow SolarEdge customers to maximise earnings by charging their batteries with cheap, clean energy when it is most abundant, and selling energy back to the grid to support supply at peak times – all fully automated by Kraken. The first to benefit from the partnership will be Octopus Energy customers in the
Roth MKM analyst Philip Shen maintains SolarEdge Technologies (NASDAQ:SEDG) with a Neutral and lowers the price target from $55 to $27.
Piper Sandler analyst Kashy Harrison maintains SolarEdge Technologies (NASDAQ:SEDG) with a Neutral and raises the price target from $25 to $29.
--Lead and Copper Rule Improvement (LCRI) Legislation Excluded From U.S. Environmental Protection Agency's (EPA) Regulatory Freeze Element 82 and PE Pipelines Well-Positioned for Continued Strong Demand-- LOS ANGELES, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading provider of innovative technology infrastructure solutions that benefit communities and the environment, today highlighted the potential impact of the incoming Trump administration on its lead pipe detection and remediation businesses, Element 82 and PE Pipelines. While many new EPA programs may face a regulatory freeze on January 20, 2025, the finalized LCRI
SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and a subsidiary of Grifols, announced today that the first patient has been dosed in a Phase 1 clinical trial evaluating the safety and tolerability of the first recombinant polyclonal drug candidate, GIGA-2339, for the treatment of hepatitis B virus (HBV) infection. "The initiation of this Phase 1 trial with GIGA-2339 represents a milestone in our mission to develop the next generation of antibody drugs for addressing infectious disease treatment," said Carter Keller, senior vice
Believes Substantially Greater Value Than Any Brookfield Bid Can Be Realized by Ousting Conflicted Directors and Restoring Majority Control of Independent Shareholders Demands Rightful Addition of Paul Herendeen to the Board via Voluntary Appointment or Shareholder Vote Mason Capital Management LLC ("Mason"), a registered investment advisor to funds and accounts holding approximately 2.1% of Grifols S.A. ("Grifols" or the "Company") (BME: GRF) (NASDAQ:GRFS) class A shares, today sent a letter to the Grifols Board of Directors (the "Board"). In the letter, Mason reiterated the Company's corporate governance deficiencies, which have inflicted large losses on all shareholders and resulted
Achieved Record Quarterly Revenue of $8.0 Million Reiterates Fourth Quarter and Full Year 2024 Revenue Guidance of $9 Million and $22 Million, Respectively Conference Call and Webcast Scheduled for Today, November 14th at 11:00 a.m. ET LOS ANGELES, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading provider of innovative technology infrastructure solutions that benefit communities and the environment, today reported its financial results for the third quarter ended September 30, 2024. "We're pleased with our strong third quarter performance, achieving record quarterly revenue of $8.0 million. Crown's results this quarter re
SolarEdge Technologies, Inc. (NASDAQ:SEDG), a global leader in smart energy technology, today announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Revenues of $260.9 million Revenues from solar segment of $247.5 million GAAP gross margin of negative 269.2%1 Non-GAAP gross margin2 of negative 265.4%1 Gross margin from solar segment of negative 245.8%1 GAAP operating loss of negative $1.09 billion1 Non-GAAP operating loss2 of $808.1 million1 GAAP net loss of negative $1.21 billion1 Non-GAAP net loss2 of negative $874.3 million1 GAAP net loss per share of negative $21.11 Non-GAAP net loss2 per share of $15.31 Imp
LOS ANGELES, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading provider of cutting edge technology solutions that benefit communities and the environment, today announced that it will report its financial results for the third quarter ended September 30, 2024, before the markets open on Thursday, November 14, 2024. The Company will host a conference call and audio webcast that morning at 11:00 a.m. Eastern Time featuring remarks by Crown's management team. Conference Call InformationDate: Thursday, November 14, 2024Time: 11:00 a.m. Eastern Time / 8:00 a.m. Pacific TimeLive Call: +1-877-451-6152 or +1-201-389-0879 or Call